Search Results 1331-1340 of 18936 for dialysis

  1. To Evaluate The Long-term Safety And Tolerability Of Acoramidis In Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) - Mayo Clinic

    Stage IV or V chronic kidney disease (corresponding to an eGFR ≤ 29 mL/min/1.73 m2), or undergoing renal dialysis, or recipient of a kidney transplant. 5 ...

  2. A Study to Determine the Impact of Ascorbic Acid Treatment on Vasodilation in Cardiac Surgery - Mayo Clinic

    Pre-operative renal dysfunction requiring dialysis. Preoperative midodrine, oral steroid, or intravenous steroid use. Inhaled steroids are not an exclusion ...

  3. Nedosiran in Pediatric Patients from Birth to 5 Years of Age with PH and Relatively Intact Renal Function - Mayo Clinic

    Currently receiving dialysis or anticipating requirement for dialysis during the study period 3. Plasma oxalate (Pox) > 30 µmol/L at Screening 4. Documented ...

  4. Ceftolozane/Tazobactam in Pediatric Patients With Nosocomial Pneumonia - Mayo Clinic

    ... dialysis, hemodialysis, or hemofiltration. For Group 5, has CrCL < 20 mL/min/1.73 m^2 based on the revised Schwartz equation or requirement for peritoneal ...

  5. Acyclovir (oral route, intravenous route) - Side effects & dosage - Mayo Clinic

    Kidney disease (eg, patients receiving dialysis)—You may need a dose adjustment. Talk with your doctor if you have concerns about this. Back to top. Proper ...

  6. Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation - Mayo Clinic

    Participation eligibility · eGFR < 30 mL/min/1.73 m2, serum creatinine > 2.5 mg/dL or requiring dialysis · Known permanent or current atrial fibrillation (history ...

  7. Critical Care - Doctors - Mayo Clinic

    Devang K. Sanghavi, M.B.B.S., M.D.. Jacksonville, FL. Areas of focus: Extracorporeal membrane oxygenation, Bronchoscopy, Dialysis, Sepsis, ARDS, Septic shock ...

  8. An Observational Study of Patients with Primary Hyperoxaluria Type 1 - Mayo Clinic

    Prior renal and/or hepatic transplantation, or patients undergoing dialysis. 2. Participation in any clinical study involving administration of any.

  9. A Study of the Safety and Effectiveness of Chronic Subcutaneous CD-NP for Renal Blood Vessel Protection for Patients who have Heart Failure and an LVAD - Mayo Clinic

    ... dialysis; Written history of alcohol or drug abuse within the past 6 months; Inability to communicate effectively with study personnel; BMI > 40. Participating ...

  10. Study to Evaluate Clinical Complications, Pattern of Kidney Function Decline and Identification of Clinical Variables Related to Progression of Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...